Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 2;14(7):2345-55.
doi: 10.3390/molecules14072345.

A new synthetic compound, 2-OH, enhances interleukin-2 and interferon-gamma gene expression in human peripheral blood mononuclear cells

Affiliations

A new synthetic compound, 2-OH, enhances interleukin-2 and interferon-gamma gene expression in human peripheral blood mononuclear cells

Shiu-Huey Chou et al. Molecules. .

Abstract

A new synthetic compound, 6-hydroxy-2-tosylisoquinolin-1(2H)-one (2-OH), was selected for immunopharmacological activity tests. The effects of 2-OH on human peripheral blood mononuclear cell (PBMC) proliferation were determined by tritiated thymidine uptake. Compared to phytohemagglutinin (PHA; 5 microg/mL) stimulation, 2-OH significantly enhanced PBMC proliferation in a dose-dependent manner. The 50% enhancement activity (EC(50)) for 2-OH was 4.4+/-0.1 microM. In addition, effects of 2-OH on interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) production in PBMC were determined by enzyme immunoassay. Results demonstrated that 2-OH stimulated IL-2 and IFN-gamma production in PBMC. Data from reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR indicated that IL-2 and IFN-gamma mRNA expression in PBMC could be induced by 2-OH. Therefore, 2-OH enhanced IL-2 and IFN-gamma production in PBMC by modulation their gene expression. We suggest that 2-OH may be an immunomodulatory agent.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The structure of 2-OH (C16H13NO4S; M.W. 315).
Figure 2
Figure 2
Effects of 2-OH on PBMC proliferation. PBMC (2×105/well) were treated with 0.1% DMSO (control), PHA (5 µg/mL) or indicated concentrations of 2-OH (1.5, 3.13, 6.25, 12.5, and 25 μM) for three days. The proliferation of cells were detected by tritiated thymidine uptake. After a 16 hr incubation, the cells were harvested by an automatic harvester then radioactivity was measured by a scintillation counting. Each bar represents the mean±S.D. of three independent experiments with PBMC from different individuals. *P < 0.05, **P< 0.01, as compared with control group.
Figure 3
Figure 3
The IL-2 and IFN-γ production in PBMC cultures treated with 2-OH. PBMC (2×105/well) were treated by 0.1% DMSO (control), PHA (5 µg/mL) or indicated concentrations of 2-OH (1.5, 3.13, 6.25, 12.5, and 25 μM) for three days. Then the cell supernatants were collected and (A) IL-2 and (B) IFN-γ concentrations were determined by EIA. Each bar is the mean±S.D. of three independent experiments with PBMC from different individuals. *P < 0.05, **P< 0.01, ***P< 0.001, as compared with control group.
Figure 4
Figure 4
Effects of 2-OH on: (A) IL-2 and (B) IFN-γ mRNA expression in PBMC, as detected with RT-PCR. PBMC (5 x 106) were cultured with PHA (5 µg/mL) or 6.25 and 25 μM 2-OH for 18 hr. The total cellular RNA was isolated from PBMC and aliquots of RNA (1 μg) were reverse-transcribed for synthesis of cDNA. PCR was done as described in Materials and Methods. Following the reaction, the amplified product was taken out of the tubes and run on 2% agarose gel. Lane 1: Control (0.1% DMSO), Lane 2: PHA, Lane 3: 6.25 μM 2-OH, Lane 4: 12.5 μM 2-OH. Each band was quantitated using laser scanning densitometer SLR-2D/1D (Biomed Instruments Inc., Fullerton, CA, USA). The ratio of IL-2 or IFN-γ mRNA to GAPDH mRNA was calculated. Each bar is the mean±S.D. of three independent experiments with PBMC from different individuals. **P < 0.01, ***P < 0.001, as compared with control group.

Similar articles

Cited by

References

    1. Numata A., Ibuka I. Alkaloids from ants and other insects. In: Brossi A., editor. The Alkaloids. Academic Press; New York, NY, USA: 1987. p. 193.
    1. Liu C.P., Tsai W.J., Lin Y.L., Liao J.F., Chen C.F., Kuo Y.C. The extracts from Nelumbo nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. Life Sci. 2004;75:699–716. doi: 10.1016/j.lfs.2004.01.019. - DOI - PubMed
    1. Liu C.P., Kuo Y.C., Lin Y.L., Liao J.F., Shen C.C., Chen C.F., Tsai W.J. (S)-Armepavine inhibits human peripheral blood mononuclear cells activation by regulating Itk and PLCγ activation in a PI3K-dependent manner. J. Leukocyte Biol. 2007;81:1276–1286. doi: 10.1189/jlb.0106056. - DOI - PubMed
    1. Liu C.P., Tsai W.J., Lin Y.L., Liao J.F., Shen C.C., Chen C.F., Kuo Y.C. Inhibitory effects of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL lpr/lpr mice. Eur. J. Pharmacol. 2006;531:270–279. doi: 10.1016/j.ejphar.2005.11.062. - DOI - PubMed
    1. San Miguel J.F., Schlag R., Khuageva N.K., Dimopoulos M.A., Shpilberg O., Kropff M., Spicka I., Petrucci M.T., Palumbo A., Samoilova O.S., Dmoszynska A., Abdulkadyrov K.M., Schots R., Jiang B., Mateos M.V., Anderson K.C., Esseltine D.L., Liu K., Cakana A., van de Velde H., Richardson P.G. VISTA Trial Investigators. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N. Engl. J. Med. 2008;359:906–917. - PubMed

Publication types

MeSH terms

LinkOut - more resources